MarketInOut Stock Screener Log In | Sign Up

Alpha Tau Medical Ltd

NASDAQ • Healthcare • Biotechnology • Quote as of 11/20/2026
Alpha Tau Medical Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,087.08 mln
Float74.16 mln
Earnings Date03/11/2027

Piotroski F-Score

3 / 9
Below average

1-Year Forecast

21.00
Transformational upside

Relative Strength

26 / 100
Underperforming

Debt / Equity

0.75
Moderate leverage

ROE

-193
Deeply negative

ROA

-95.19
Deeply negative

Business Description

Alpha Tau Medical is an Israel-based medical company developing a new type of radiation treatment for solid tumors called Alpha DaRT. The therapy works by placing small radioactive seeds directly into a tumor, where they release high-energy alpha particles to destroy cancer cells. The company is currently testing this approach in clinical trials across a wide range of cancer types, including skin, prostate, pancreatic, lung, liver, and breast cancers.

Key Fundamentals

EPS-1.04
ROE-193
ROIC-181
ROA-95.19
Interest Cover-0.90
EBITDA, mln-52.40
EV / EBITDA-19.17
EV / EBIT-19.17

Quote Details

Last 11.76
Change 0.45 (3.98%)
Open 11.47
Volume 621,961
Turnover 7,314,262
Average Volume 652,504

Financial Ratios

Leverage Ratio6.56
Current Ratio9.46
Price / Book55.71
Price / Tangible Book55.98
Debt / Equity0.75

Financial Strength

Piotroski F-Score 3 / 9
1-Year Target Price21.00
Short Ratio8.56
Short % of Float6.10

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -12.11% 30 / 100   
1 Month -8.84% 47 / 100   
2 Months -16.89% 41 / 100   
6 Months 17.13% 92 / 100   
1 Year 220% 99 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog